Market
EQT to buy diagnostics player Qiagen for €9.6bn
EQT Partners agreed to acquire Qiagen, a diagnostics equipment and consumables manufacturer, for €9.6 billion. The transaction marks a significant consolidation in the in vitro diagnostics sector and follows sustained private-equity interest in the company.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network